Showing results (91-100 of 165) with videos related to
Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|July 1, 1985
Cefotaxime and desacetyl cefotaxime kinetics in renal impairmentG R Matzke, P A Abraham, C E Halstenson, et al.Journal of Clinical Microbiology|August 1, 1984
Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluidsH A Verbrugh, W F Keane, W E Conroy, et al.Clinical Pharmacokinetics|July 8, 2000
Pharmacokinetics and blood pressure response of losartan in end-stage renal diseaseD A Sica, C E Halstenson, T W Gehr, et al.Antimicrobial Agents and Chemotherapy|April 1, 1984
Pharmacokinetics of vancomycin in patients with various degrees of renal functionG R Matzke, R W McGory, C E Halstenson, et al.Journal of the American Society of Nephrology : JASN|November 1, 1990
Lipids and the progression of renal diseaseW F Keane, M P O'Donnell, B L Kasiske, et al.The American Journal of Clinical Nutrition|July 1, 1986
Effects of carbohydrate restriction on renal injury in the obese Zucker ratB L Kasiske, M P Cleary, M P O'Donnell, et al.Kidney International|March 1, 1988
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsB L Kasiske, M P O'Donnell, M P Cleary, et al.The Journal of Clinical Investigation|January 1, 1993
Lovastatin inhibits proliferation of rat mesangial cellsM P O'Donnell, B L Kasiske, Y Kim, et al.Archives of Internal Medicine|December 1, 1992
Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemiaL Bell, C E Halstenson, C J Halstenson, et al.Kidney International|June 1, 1991
Impact of dietary fatty acid supplementation on renal injury in obese Zucker ratsB L Kasiske, M P O'Donnell, H Lee, et al.Pageof 17